• Wed, February 23, 2022

by: WOPRAI

Lawrence Biegelsen Maintained (TNDM) at Buy with Increased Target to $166 on, Feb 23rd, 2022

by: WOPRAI

Matthew Boss Maintained (TJX) at Buy and Held Target at $81 on, Feb 23rd, 2022

by: WOPRAI

Simeon Siegel Maintained (TJX) at Buy with Decreased Target to $75 on, Feb 23rd, 2022

by: WOPRAI

Mark Altschwager Maintained (TJX) at Buy and Held Target at $78 on, Feb 23rd, 2022

by: WOPRAI

Adrienne Yih Maintained (TJX) at Buy and Held Target at $94 on, Feb 23rd, 2022

by: WOPRAI

Toni Kaplan Downgraded (TRU) to Hold and Held Target at $102 on, Feb 23rd, 2022

by: WOPRAI

Kevin Mcveigh Maintained (TRU) at Hold with Decreased Target to $105 on, Feb 23rd, 2022

by: WOPRAI

Andrew Steinerman Maintained (TRU) at Buy with Decreased Target to $124 on, Feb 23rd, 2022

by: WOPRAI

Shlomo Rosenbaum Maintained (TRU) at Strong Buy with Decreased Target to $118 on, Feb 23rd, 2022

by: WOPRAI

Michael Phillips Maintained (TRV) at Hold with Increased Target to $185 on, Feb 23rd, 2022

by: WOPRAI

Blair Abernethy Maintained (CDNS) at Strong Buy with Increased Target to $180 on, Feb 23rd, 2022

by: WOPRAI

Ruben Roy Upgraded (CDNS) to Strong Buy and Held Target at $180 on, Feb 23rd, 2022

by: WOPRAI

Jackson Ader Maintained (CDNS) at Hold with Decreased Target to $175 on, Feb 23rd, 2022

by: WOPRAI

Ryan Levine Maintained (CNP) at Hold with Increased Target to $29 on, Feb 23rd, 2022

by: WOPRAI

Matthew Galinko Initiated (CPTN) at Strong Buy and Held Target at $220 on, Feb 23rd, 2022

by: WOPRAI

Clarke Jeffries Maintained (SPT) at Buy with Decreased Target to $98 on, Feb 23rd, 2022

by: WOPRAI

Raimo Lenschow Maintained (SPT) at Buy with Decreased Target to $73 on, Feb 23rd, 2022

by: WOPRAI

Scott Berg Maintained (SPT) at Strong Buy with Decreased Target to $75 on, Feb 23rd, 2022

by: WOPRAI

Stan Zlotsky Maintained (SPT) at Hold with Decreased Target to $70 on, Feb 23rd, 2022

by: WOPRAI

Parker Lane Maintained (SPT) at Strong Buy with Decreased Target to $100 on, Feb 23rd, 2022

by: WOPRAI

Josh Beck Maintained (SQ) at Buy with Decreased Target to $175 on, Feb 23rd, 2022

by: WOPRAI

Raimo Lenschow Upgraded (SMWB) to Buy and Held Target at $22 on, Feb 23rd, 2022

by: WOPRAI

Sean Horgan Maintained (SOFI) at Strong Buy with Decreased Target to $22 on, Feb 23rd, 2022

by: WOPRAI

Puneet Souda Maintained (A) at Buy with Decreased Target to $145 on, Feb 23rd, 2022

by: WOPRAI

Patrick Donnelly Maintained (A) at Strong Buy with Decreased Target to $175 on, Feb 23rd, 2022

by: WOPRAI

Daniel Arias Maintained (A) at Hold with Decreased Target to $145 on, Feb 23rd, 2022

by: WOPRAI

Dan Leonard Maintained (A) at Buy with Decreased Target to $160 on, Feb 23rd, 2022

by: WOPRAI

Dan Brennan Maintained (A) at Buy with Decreased Target to $178 on, Feb 23rd, 2022

by: WOPRAI

Derik De Bruin Maintained (A) at Strong Buy with Decreased Target to $160 on, Feb 23rd, 2022

by: WOPRAI

Ross Muken Maintained (A) at Buy with Decreased Target to $155 on, Feb 23rd, 2022

by: WOPRAI

Siti Panigrahi Maintained (ZM) at Strong Buy with Decreased Target to $190 on, Feb 23rd, 2022

by: WOPRAI

Gary Nachman Maintained (ABBV) at Buy with Increased Target to $161 on, Feb 23rd, 2022

by: WOPRAI

Marcella Recchia Upgraded (ARCO) to Buy and Held Target at $9.5 on, Feb 23rd, 2022

by: WOPRAI

Li Watsek Initiated (AFMD) at Buy and Held Target at $120 on, Feb 23rd, 2022

by: WOPRAI

Karl Keirstead Maintained (ADBE) at Hold with Decreased Target to $460 on, Feb 23rd, 2022

by: WOPRAI

Simon Yarmak Maintained (ADC) at Strong Buy and Held Target at $81 on, Feb 23rd, 2022

by: WOPRAI

Fahad Najam Initiated (ADTN) at Hold and Held Target at $21 on, Feb 23rd, 2022

by: WOPRAI

Keith Weiss Maintained (ADSK) at Hold with Decreased Target to $277 on, Feb 23rd, 2022

by: WOPRAI

Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $339 on, Feb 23rd, 2022

by: WOPRAI

Michael Rehaut Maintained (BLD) at Hold with Decreased Target to $278 on, Feb 23rd, 2022

by: WOPRAI

Parker Lane Maintained (BLKB) at Hold with Decreased Target to $70 on, Feb 23rd, 2022

by: WOPRAI

Emmanuel Rosner Maintained (AXL) at Hold with Decreased Target to $10 on, Feb 23rd, 2022

by: WOPRAI

Verity Mitchell Upgraded (AWK) to Strong Buy and Decreased Target to $182 on, Feb 23rd, 2022

by: WOPRAI

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $31 on, Feb 23rd, 2022

by: WOPRAI

Abhi Agarwal Maintained (AU) at Strong Buy with Increased Target to $24 on, Feb 23rd, 2022

by: WOPRAI

James Ratcliffe Downgraded (ATUS) to Hold and Decreased Target to $15 on, Feb 23rd, 2022

by: WOPRAI

Nick Lyall Downgraded (ATUS) to Hold and Held Target at $12 on, Feb 23rd, 2022

by: WOPRAI

Sanjit Singh Maintained (BASE) at Hold with Decreased Target to $24 on, Feb 23rd, 2022

Lawrence Biegelsen Maintained (TNDM) at Buy with Increased Target to $166 on, Feb 23rd, 2022

Lawrence Biegelsen of Wells Fargo, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Increased Target from $160 to $166 on, Feb 23rd, 2022.

Lawrence has made no other calls on TNDM in the last 4 months.



There is 1 other peer that has a rating on TNDM. Out of the 1 peers that are also analyzing TNDM, 0 agree with Lawrence's Rating of Hold.



This is the rating of the analyst that currently disagrees with Lawrence

  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $138 on, Thursday, November 4th, 2021

Like: 👍